Rubin Jonathan

CIK 00018360671 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001836067

Recent Transactions

50 trades

Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-25$46.21/sh−840→ 11,015 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-25+1,875→ 11,855 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-09-25−1,875→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-09-10+1,875→ 1,875 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−314→ 10,789 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−577→ 10,212 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−577→ 9,635 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−1,250→ 2,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+1,250→ 11,103 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+750→ 8,603 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−1,250→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+1,250→ 9,853 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−750→ 750 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21+1,875→ 8,780 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21$39.15/sh−927→ 7,853 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-21−1,875→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-01-28+1,875→ 1,875 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+750→ 5,822 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−1,875→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−750→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+1,875→ 7,416 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−821→ 6,595 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−281→ 5,541 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-23+1,875→ 1,875 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-23+750→ 750 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−567→ 4,641 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+1,250→ 5,208 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−1,250→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22+5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+750→ 4,261 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22$27.94/sh−303→ 3,958 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22−750→ 1,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-02-22+25,000→ 25,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-12-22−600→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-12-22$27.66/sh−204→ 3,243 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-12-22+600→ 3,447 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-12-14+600→ 600 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-23+5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2023-02-23+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+750→ 2,497 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−750→ 2,250 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-02-16−1,500→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-16+1,500→ 1,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-01-12+1,500→ 1,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+25,000→ 25,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+25,000→ 25,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,000→ 3,000 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
SVP, Chief Medical Officer
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov